Yombo Dispensary
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MÃ¥rtensson, Andreas
3ACT, NCT05764746: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Recruiting
2/3
384
RoW
Artemether-lumefantrine and Amodiaquine Drug Combination, AL+AQ, Artemether-lumefantrine then Artesunate amodiaquine, AL then ASAQ, Artemether-lumefantrine, AL + Placebo
Muhimbili University of Health and Allied Sciences, The Swedish Research Council, Uppsala University
Uncomplicated Plasmodium Falciparum Malaria
12/24
12/24
Martensson, Andreas
PBT, NCT05709522: Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients

Recruiting
N/A
80
RoW
Neurocognitive tools, Psychosocial tools
Aga Khan University, Jinnah Postgraduate Medical Centre
Brain Tumor, Pediatric, Blood Cancer
11/23
11/23
Mhamilawa, Lwidiko E
3ACT, NCT05764746: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Recruiting
2/3
384
RoW
Artemether-lumefantrine and Amodiaquine Drug Combination, AL+AQ, Artemether-lumefantrine then Artesunate amodiaquine, AL then ASAQ, Artemether-lumefantrine, AL + Placebo
Muhimbili University of Health and Allied Sciences, The Swedish Research Council, Uppsala University
Uncomplicated Plasmodium Falciparum Malaria
12/24
12/24
Ngasala, Billy E
3ACT, NCT05764746: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Recruiting
2/3
384
RoW
Artemether-lumefantrine and Amodiaquine Drug Combination, AL+AQ, Artemether-lumefantrine then Artesunate amodiaquine, AL then ASAQ, Artemether-lumefantrine, AL + Placebo
Muhimbili University of Health and Allied Sciences, The Swedish Research Council, Uppsala University
Uncomplicated Plasmodium Falciparum Malaria
12/24
12/24
Hemedi, Ramadhani
3ACT, NCT05764746: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Recruiting
2/3
384
RoW
Artemether-lumefantrine and Amodiaquine Drug Combination, AL+AQ, Artemether-lumefantrine then Artesunate amodiaquine, AL then ASAQ, Artemether-lumefantrine, AL + Placebo
Muhimbili University of Health and Allied Sciences, The Swedish Research Council, Uppsala University
Uncomplicated Plasmodium Falciparum Malaria
12/24
12/24

Download Options